A line of syringes manufactured by Cardinal Health may fail to properly inject insulin when used with needleless IV connectors.
The methods enable providers to identify signs of sepsis by assessing blood flow throughout the muscles.
The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.
